Trials / Completed
CompletedNCT05277038
Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Salem Anaesthesia Pain Clinic · Academic / Other
- Sex
- All
- Age
- 20 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights. Each patient used a special validated sleep diary to collect data including pain score, sleep scores, sleep duration, sleep medication dose, and adverse effects. Each patient completed the diary for 3 continuous weeks. Pain was measured using the numeric pain rating scale. Sleep score was measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points was considered significant.
Detailed description
Objectives: Chronic pain is associated with insomnia. The objective of this clinical study is to compare the efficacy and safety of different prescribed doses of Zopiclone and Clonidine; for the management of insomnia in patients with chronic pain. Methods: A prospective observational crossover study of 160 consenting adult patients who underwent pain management. For insomnia treatment, each patient ingested different prescribed doses of Zopiclone or Clonidine on alternate nights. Each patient used a special validated sleep diary to collect data including pain score, sleep scores, sleep duration, sleep medication dose, and adverse effects. Each patient completed the diary for 3 continuous weeks. Pain was measured using the numeric pain rating scale. Sleep score was measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points was considered significant. Data were analyzed with IBM® SPSS® Statistics 25 (IBM Corp, Armonk, NY); using Student's t-test, ANOVA, Pearson Chi-square test, and regression analysis. P-value \<0.05 was considered significant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clonidine 0.1mg pill | Routine prescription for insomnia |
| DRUG | Clonidine 0.2mg pill | Routine prescription for insomnia |
| DRUG | Zopiclone 3.75mg pill | Routine prescription for insomnia |
| DRUG | Zopiclone 7.5mg pill | Routine prescription for insomnia |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-11-05
- Completion
- 2022-11-05
- First posted
- 2022-03-14
- Last updated
- 2022-11-18
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05277038. Inclusion in this directory is not an endorsement.